Singapore-Japan Fast Track Pitch Event
Message from Leadership
Sharon Chan, Head of Johnson & Johnson Innovation – JLABS (JLABS), Asia Pacific
A great idea can come from anywhere. Our mission is to unlock the potential of life science innovation no matter where it originates. Johnson & Johnson Innovation teams aim to solve the world’s toughest health challenges and drive scientific breakthroughs that improve health for everyone, everywhere. We know that a great idea can come from anywhere and we are proud of our strong track record of cultivating innovation and pairing our deep internal know-how with some of the most promising external innovation from around the globe.
Johnson & Johnson's Challenge
| Challenges | Worldwide, cancer cases and mortality are expected to increase significantly due to aging and increasing populations, with over half of new diagnoses already occurring in Asia. Thanks to scientific advances and new collaborations, there's reason for hope —and the Janssen Pharmaceutical Companies of Johnson & Johnson are at the forefront of this crucial work. To advance the next generation of innovations, Janssen is seeking to partner with companies with scientific assets under development ((1 year to IND or later stage) in accelerating science and treatments to address hematologic malignancies, including B-cell malignancies, plasma cell malignancies, and myeloid malignancies, as well as solid tumours, such as prostate cancer, non-small cell lung cancer, bladder cancer and colorectal cancer. |
|---|---|
| Collaboration Needs | Scientific assets under development ((1 year to IND or later stage) in accelerating science and treatments to address hematologic malignancies, including B-cell malignancies, plasma cell malignancies, and myeloid malignancies, as well as solid tumours, such as prostate cancer, non-small cell lung cancer, bladder cancer and colorectal cancer. |
| Challenges |
(1) Contact lens Johnson & Johnson Vision is looking to identify technologies for the next generation of Contact Lenses to advance standards of eye care from Pediatric to Aging Eyes. We are looking for R&D collaboration and product/service co-development opportunities to improve quality of vision, comfort and ocular health. Areas of specific interest include (among others):
A cataract is the clouding of the crystaline lens in the eye, which can lead to vision impairment and potentially blindness. Cataracts remains the world’s leading cause of reversible blindness. Cataract surgery is the world’s most widely performed surgery with high success rates in restoring vision and enhancing quality of life. However, opportunities remain for improvements in the precision of refractive outcomes, visual quality and range of vision (near to distance) as demands on the visual system increase across age groups and patients desire to be spectacle independent. Johnson & Johnson Vision is seeking opportunities for R&D collaboration and product/service co-development in the areas of cataract and corneal refractive surgery. (3) Ocular Drug delivery Ocular drugs are commonly delivered via eye drops, which many patients find challenging to use and are often associated with poor compliance. Johnson & Johnson Vision is interested in opportunities for R&D collaboration and product/service co-development for ocular drug delivery technologies with the potential to improve patient outcomes. Johnson & Johnson Vision is looking for R&D collaboration or co-development opportunities for product / solutions for ocular drug delivery technologies for
According to the WHO, 50% of the world's population will be myopic by 2050. Johnson & Johnson Vision is looking for R&D collaboration or co-development opportunities for potential treatments for myopia progression, predicative tools for identifying children at high risk of progression and tools for parents to monitor myopic progression. According to the World Health Organization (WHO), 50% of the world's population will be myopic by 2050. 1 billion people will have high myopia (＜-5.00D) and a 70% risk of visual impairment at a later age in life. The problem is most severe in Asia, where the prevalence of myopia in those aged 18 years is >80% in several countries. Johnson & Johnson Vision is looking for R&D collaboration or co-development opportunities for product / service / solutions for Myopia management, Myopia Management innovation areas of interest include:
|
|---|---|
| Collaboration Needs |
(1) Contact lens We are looking for the following:
We have an interest in:
We are looking for technologies related to:
Myopia Management innovation areas of interest include:
|
| Opportunity | We are looking for R&D collaboration and product/service co-development opportunities to improve quality of vision, comfort and ocular health across various potential solutions. |
| Challenges |
(1) Orthopedic Trauma The surgical episode of care can be inefficient and unpredictable for surgeons, care teams, and patients. Common unmet needs could include:
|
|---|---|
| Collaboration Needs |
|
| Opportunity |
|
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. Every day, our more than 140,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.
